Author

Gianluca Breghi

Observed institution: GlaxoSmithKline (Italy)

OpenAlex ID: A5012924832

Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis

2022 · Christian S Marchello, Megan Birkhold, et al. · The Lancet Infectious Diseases · 271

Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis

2021 · Christian S. Marchello, Fabio Fiorino, et al. · Journal of Infection · 104

Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial

2025 · Brama Hanumunthadu, Tesfaye Demissie, et al. · EBioMedicine · 16

The role of vaccines and vaccine decision-making to achieve the goals of the Grand Convergence in public health

2016 · David C. Kaslow, Jorge Kalil, et al. · Vaccine · 16

Effectiveness of iNTS vaccination in sub-Saharan Africa

2025 · Daniele Cassese, Nicola Dimitri, et al. · Scientific Reports · 6

PA-114 Addressing causes and underfunding of neglected disease of Low-Income Countries (LICs) synergizing national and EU funding

2023 · Gianluca Breghi · BMJ Global Health

Book Review Section and Communications

1988 · Gianluca Breghi · Journal of Macromarketing

Works count: 7

Citation count: 413

H-index: 5

I10-index: 4